The Norwegian Institute of Public Health would like to procure vaccines against Hepatitis B for the national vaccination programme.
In 2014 the Norwegian Institute of Public Health will procure 45 000 child doses (0-15 years) and 8 000 adult doses (16 or older) of the vaccine against Hepatitis B for use in the vaccination programme. The Norwegian Institute of Public Health expects that the consumption of the vaccination against Hepatitis B will stay relatively stable. The Norwegian Institute of Public Health requires, therefore that tenderers have the capacity to deliver at least 49 500 doses for children and 8 800 doses for adults per annum.
The Ministry of Health and Care Services has given the Norwegian Institute of Public Health the task of preparing a draft for a strategy for viral hepatitises. One of the points that is to be reviewed is the possibility to include the vaccine against Hepatitis B in the child vaccination programme. If it is included in the child vaccination programme, there will be consequences for the extent of this procurement. As a result of this, the Norwegian Institute of Public Health is announcing a 1-one year contract, with an option for an extension of 1+1+1 years.
In order to minimise any disadvantages connected to the length, the Norwegian Institute of Public Health is offering to procure a minimum volume of 45 000 child doses (0 - 15 years) and 8 000 adult doses (16 or older) respectively.
See the tender documentation and annexes for a complete description.
Frist
Fristen for mottak av tilbud var 2014-10-30.
Anskaffelsen ble publisert 2014-09-18.
Kunngjøring av konkurranse (2014-09-18) Gjenstand Anskaffelsens omfang
Tittel: Hepatitis B vaccines
Antall eller omfang:
“In 2014 the Norwegian Institute of Public Health will procure 45 000 child doses and 8 000 adult doses of the vaccine against Hepatitis B. The consumption...”
Antall eller omfang
In 2014 the Norwegian Institute of Public Health will procure 45 000 child doses and 8 000 adult doses of the vaccine against Hepatitis B. The consumption is expected to stay relatively stable.The contract will start as soon as it is signed. The contract has a duration of 1 year.The Norwegian Institute of Public Health draws attention to the fact that this is only an estimate and the contracting authority is, thus, not bound by the estimated volume.The contracting authority has an option to extend the contract for a further 3 years, with up to 1 year at a time on unchanged terms. The total possible contract length is 4 years (1+1+1+1).5 000 00024 000 000
Vis mer Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner mot hepatitt B📦
Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet
Oppdragsgiver Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Nasjonalt eller føderalt byrå/kontor
Navn på tildelende myndighet: Nasjonalt folkehelseinstitutt
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no🌏
E-post: ole.andreas.fuglesang@fhi.no📧
Telefon: +47 21077000📞
“In order to get access to additional information, changes, questions and answers, etc., all interested suppliers are requested to register their interest in...”
In order to get access to additional information, changes, questions and answers, etc., all interested suppliers are requested to register their interest in the tender in Doffin.